Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
of our reports dated March 14, 2024 with respect to the consolidated financial statements of Arcturus Therapeutics Holdings Inc. and the effectiveness of internal control over financial reporting of Arcturus Therapeutics Holdings, Inc., included in this Annual Report (Form 10-K) of Arcturus Therapeutics Holdings, Inc. for the year ended December 31, 2023.
/s/ Ernst & Young LLP
San Diego, California
March 14, 2024